DOPAMINERGIC AGONIST NOMIFENSINE COMPARED WITH AMITRIPTYLINE - DOUBLE-BLIND CLINICAL-TRIAL IN ACUTE PRIMARY DEPRESSIONS

被引：21

作者：

GROF, P

SAXENA, B

DAIGLE, L

MAHUTTE, G

机构：

[1] MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA

[2] HAMILTON PSYCHIAT HOSP,AFFECT DISORDERS CLIN,RES UNIT,HAMILTON,ONTARIO,CANADA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 4卷

关键词：

D O I：

10.1111/j.1365-2125.1977.tb05756.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S221 / S225

页数：5

共 14 条

[1] RESULTS OF AN OPEN AND A DOUBLE-BLIND STUDY OF NOMIFENSIN IN COMPARISON TO IMIPRAMIN [J].

ANGST, J ;

KOUKKOU, M ;

BLEULERH.M ;

MARTENS, H .

ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1974, 219 (03) :265-276

[2]

BIAMINO G, 1976, 1976 AL S ERG EXPT K

[3] NOMIFENSINE - POTENT DOPAMINERGIC AGONIST OF ANTIPARKINSON POTENTIAL [J].

COSTALL, B ;

KELLY, DM ;

NAYLOR, RJ .

PSYCHOPHARMACOLOGIA, 1975, 41 (02) :153-164

[4] DIAGNOSTIC CRITERIA FOR USE IN PSYCHIATRIC RESEARCH [J].

FEIGHNER, JP ;

WOODRUFF, RA ;

WINOKUR, G ;

MUNOZ, R ;

ROBINS, E ;

GUZE, SB .

ARCHIVES OF GENERAL PSYCHIATRY, 1972, 26 (01) :57-&

[5]

FRANCHINI EA, 1973, REV BRASIL CLIN TERA, V2, P317

[6]

HOFFMANN I, 1973, ARZNEIMITTEL-FORSCH, V23, P45

[7] NOMIFENSINE - NEW POTENT INHIBITOR OF DOPAMINE UPTAKE INTO SYNAPTOSOMES FROM RAT-BRAIN CORPUS STRIATUM [J].

HUNT, P ;

KANNENGIESSER, MH ;

RAYNAUD, JP .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (05) :370-371

[8]

LEON P, 1974, ACTA MEDICA PERUANA, V3, P202

[9]

MADALENA JC, 1973, REV BRASIL CLIN TERA, V2, P311

[10]

PECKNOLD JC, 1975, INT J CLIN PHARM BI, V11, P304

← 1 2 →